Daniel Petrylak(@DanielPetrylak) 's Twitter Profileg
Daniel Petrylak

@DanielPetrylak

ID:1616391828

calendar_today24-07-2013 00:26:36

214 Tweets

601 Followers

321 Following

Follow People
Journal for ImmunoTherapy of Cancer(@jitcancer) 's Twitter Profile Photo

New article: First-in-human, phase 1 study of PF-06753512, a vaccine-based immunotherapy regimen (VBIR), in non-metastatic hormone-sensitive biochemical recurrence and metastatic castration-resistant prostate cancer (mCRPC) bit.ly/42rwFDf Daniel Petrylak

New #JITC article: First-in-human, phase 1 study of PF-06753512, a vaccine-based immunotherapy regimen (VBIR), in non-metastatic hormone-sensitive biochemical recurrence and metastatic castration-resistant prostate cancer (mCRPC) bit.ly/42rwFDf @DanielPetrylak
account_circle
Toni Choueiri, MD(@DrChoueiri) 's Twitter Profile Photo

Masterful presentation by Daniel Petrylak
Results from cohort 2 of TROPHY-U-01: ph 2 SG in PT-ineligible pts w/ mUC that progressed after CPI
32% of CR, mPFS of 5.6mo, mOS of 13.5mo
Awaiting results from other cohorts!
Yale Cancer Center
OncoAlert

#GU23 Masterful presentation by @DanielPetrylak Results from cohort 2 of TROPHY-U-01: ph 2 SG in PT-ineligible pts w/ mUC that progressed after CPI 32% of CR, mPFS of 5.6mo, mOS of 13.5mo Awaiting results from other cohorts! @YaleCancer @OncoAlert
account_circle
PER(@gotoPER) 's Twitter Profile Photo

Join Dr. Leonard G. Gomella of Sidney Kimmel Cancer Center – Jefferson Health and Daniel Petrylak of Yale School of Medicine for the 16th Annual NYGU™ conference , taking place from March 10-11. Use code NYGU35S for 35% off registration: ow.ly/HLMq50MBiRa

Join Dr. Leonard G. Gomella of @KimmelCancerCtr and @DanielPetrylak of @YaleMed for the 16th Annual NYGU™ conference , taking place from March 10-11. Use code NYGU35S for 35% off registration: ow.ly/HLMq50MBiRa #gotoper #genitourinary #cme
account_circle
Daniel Petrylak(@DanielPetrylak) 's Twitter Profile Photo

Dave Crawford opens the 33rd and last International Prostate Cancer Update in Vail. I’ve been fortunate to participate in 20 of them. A great run!! Congrats Dave

Dave Crawford opens the 33rd and last International Prostate Cancer Update in Vail. I’ve been fortunate to participate in 20 of them. A great run!! Congrats Dave
account_circle
OncLive.com(@OncLive) 's Twitter Profile Photo

Don't miss some updates from Daniel Petrylak, of Yale School of Medicine, live here at ESMO - Eur. Oncology!! Dr. Petrylak stopped by to share some key points on his presentation in mHSPC! Check back on our site for more.

Don't miss some updates from @DanielPetrylak, of @YaleMed, live here at @myESMO!! Dr. Petrylak stopped by to share some key points on his presentation in mHSPC! Check back on our site for more. #ESMO2022
account_circle
OncLive.com(@OncLive) 's Twitter Profile Photo

In this episode of , Daniel Petrylak, of Yale Cancer Center, discusses current issues w/ genetic testing in prostate & bladder cancer, as well as the importance of multidisciplinary mgmt during testing & when seeking to mitigate AEs. ow.ly/Lku250Kqlib

In this episode of #OncLiveOnAir, @DanielPetrylak, of @YaleCancer, discusses current issues w/ genetic testing in prostate & bladder cancer, as well as the importance of multidisciplinary mgmt during testing & when seeking to mitigate AEs. #blcsm #pcsm ow.ly/Lku250Kqlib
account_circle
Yale Cancer Center(@YaleCancer) 's Twitter Profile Photo

Exciting findings from new research led by Daniel Petrylak validate novel effective therapy for aggressive muscle-invasive . Data to be presented Friday at . Smilow Cancer Hospital Yale School of Medicine Yale New Haven Hosp @YaleUrology ASCO yalecancercenter.org/news-article/y…

Exciting findings from new research led by @DanielPetrylak validate novel effective therapy for aggressive muscle-invasive #bladdercancer. Data to be presented Friday at #ASCOGU22. @SmilowCancer @YaleMed @YNHH @YaleUrology @ASCO yalecancercenter.org/news-article/y…
account_circle